Search
Camicinal
go.drugbank.com/drugs/DB12567InvestigationalCamicinal has been used in trials studying the treatment of Gastroparesis.
Dilanubicel
go.drugbank.com/drugs/DB18722InvestigationalDilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.
RO-4987655
go.drugbank.com/drugs/DB12933InvestigationalRO4987655 has been used in trials studying the treatment of Neoplasms.
Nimustine
go.drugbank.com/drugs/DB13069InvestigationalNimustine has been used in trials studying the treatment of Glioblastoma.
Norvaline
go.drugbank.com/drugs/DB04185InvestigationalNorvaline is an isomer of the more common amino acid valine.
Bacteriochlorophyll A
go.drugbank.com/drugs/DB01853ExperimentalA specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.
SARS-CoV-2 Sclamp
go.drugbank.com/drugs/DB15849InvestigationalAs of July 13, 2020, the candidate is being tested for safety and immunogenicity in Phase 1 clinical trials in Queensland (ACTRN12620000674932). … The vaccine was developed using UQ’s rapid response ‘molecular clamp’ vaccine platform that locks surface proteins in a configuration that allows more robust immune responses, in combination with a well-established
UB-612
go.drugbank.com/drugs/DB16444InvestigationalIt was able to reduce viral load and prevent COVID-19 infection in a mouse challenge model and in rhesus macaques[L30653, L30658]. … In rats, toxicity studies have so far shown favourable safety for this vaccine[L30653, L30658], Phase 1 trial is currently ongoing in Taiwan (NCT04545749).
Desonide
go.drugbank.com/drugs/DB01260ApprovedInvestigationalA nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.
Mixtures: APOLAR N, DESOLEX-NNizubaglustat
go.drugbank.com/drugs/DB21603InvestigationalNizubaglustat is under investigation in clinical trial NCT07054515 (A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type … The usage of the INN stem '-glustat' in the name indicates that Nizubaglustat is a ceramide glucosyltransferase inhibitor.